Original
Asociación de simvastatina con ezetimiba como alternativa terapéutica en el control lipídico de enfermos renales crónicos en estadio 3-4. Resultados a un año
Association of simvastatin with ezetimibe as lipid control alternative therapy of chronic renal disease, stage 3-4. One year results
Leído
6072
Vecesse ha leído el artículo
974
Total PDF
5098
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 18 | 10 | 28 |
| 2025 11 | 53 | 16 | 69 |
| 2025 10 | 59 | 17 | 76 |
| 2025 9 | 46 | 16 | 62 |
| 2025 8 | 65 | 11 | 76 |
| 2025 7 | 41 | 7 | 48 |
| 2025 6 | 50 | 7 | 57 |
| 2025 5 | 37 | 7 | 44 |
| 2025 4 | 67 | 7 | 74 |
| 2025 3 | 62 | 3 | 65 |
| 2025 2 | 42 | 4 | 46 |
| 2025 1 | 39 | 3 | 42 |
| 2024 12 | 55 | 3 | 58 |
| 2024 11 | 50 | 2 | 52 |
| 2024 10 | 47 | 8 | 55 |
| 2024 9 | 65 | 6 | 71 |
| 2024 8 | 50 | 5 | 55 |
| 2024 7 | 84 | 6 | 90 |
| 2024 6 | 59 | 10 | 69 |
| 2024 5 | 75 | 4 | 79 |
| 2024 4 | 41 | 4 | 45 |
| 2024 3 | 71 | 10 | 81 |
| 2024 2 | 76 | 7 | 83 |
| 2024 1 | 66 | 8 | 74 |
| 2023 12 | 67 | 33 | 100 |
| 2023 11 | 63 | 20 | 83 |
| 2023 10 | 76 | 10 | 86 |
| 2023 9 | 41 | 11 | 52 |
| 2023 8 | 55 | 15 | 70 |
| 2023 7 | 88 | 18 | 106 |
| 2023 6 | 67 | 4 | 71 |
| 2023 5 | 78 | 8 | 86 |
| 2023 4 | 38 | 2 | 40 |
| 2023 3 | 62 | 2 | 64 |
| 2023 2 | 55 | 3 | 58 |
| 2022 1 | 72 | 9 | 81 |
| 2022 12 | 39 | 8 | 47 |
| 2022 11 | 59 | 5 | 64 |
| 2022 10 | 45 | 8 | 53 |
| 2022 9 | 45 | 8 | 53 |
| 2022 8 | 54 | 7 | 61 |
| 2022 7 | 47 | 7 | 54 |
| 2022 6 | 27 | 6 | 33 |
| 2022 5 | 29 | 10 | 39 |
| 2022 4 | 31 | 16 | 47 |
| 2022 3 | 53 | 10 | 63 |
| 2022 2 | 49 | 5 | 54 |
| 2021 1 | 62 | 7 | 69 |
| 2021 12 | 76 | 16 | 92 |
| 2021 11 | 53 | 6 | 59 |
| 2021 10 | 93 | 21 | 114 |
| 2021 9 | 60 | 9 | 69 |
| 2021 8 | 62 | 5 | 67 |
| 2021 7 | 39 | 11 | 50 |
| 2021 6 | 26 | 9 | 35 |
| 2021 5 | 37 | 9 | 46 |
| 2021 4 | 82 | 5 | 87 |
| 2021 3 | 53 | 11 | 64 |
| 2021 2 | 47 | 9 | 56 |
| 2020 1 | 59 | 11 | 70 |
| 2020 12 | 42 | 6 | 48 |
| 2020 11 | 81 | 7 | 88 |
| 2020 10 | 36 | 5 | 41 |
| 2020 9 | 39 | 12 | 51 |
| 2020 8 | 48 | 21 | 69 |
| 2020 7 | 28 | 4 | 32 |
| 2020 6 | 33 | 9 | 42 |
| 2020 5 | 49 | 6 | 55 |
| 2020 4 | 57 | 6 | 63 |
| 2020 3 | 57 | 7 | 64 |
| 2020 2 | 76 | 23 | 99 |
| 2020 1 | 57 | 14 | 71 |
| 2019 12 | 64 | 12 | 76 |
| 2019 11 | 48 | 9 | 57 |
| 2019 10 | 45 | 9 | 54 |
| 2019 9 | 68 | 10 | 78 |
| 2019 8 | 69 | 3 | 72 |
| 2019 7 | 56 | 18 | 74 |
| 2019 6 | 103 | 43 | 146 |
| 2019 5 | 205 | 51 | 256 |
| 2019 4 | 91 | 16 | 107 |
| 2019 3 | 37 | 8 | 45 |
| 2019 2 | 28 | 11 | 39 |
| 2019 1 | 23 | 8 | 31 |
| 2018 12 | 34 | 6 | 40 |
| 2018 11 | 34 | 3 | 37 |
| 2018 10 | 29 | 17 | 46 |
| 2018 9 | 26 | 5 | 31 |
| 2018 8 | 16 | 8 | 24 |
| 2018 7 | 10 | 7 | 17 |
| 2018 6 | 7 | 8 | 15 |
| 2018 5 | 7 | 6 | 13 |
| 2018 4 | 8 | 4 | 12 |
| 2018 3 | 11 | 1 | 12 |
| 2018 2 | 10 | 2 | 12 |
| 2018 1 | 13 | 5 | 18 |
| 2017 12 | 14 | 4 | 18 |
| 2017 11 | 10 | 2 | 12 |
| 2017 10 | 14 | 5 | 19 |
| 2017 9 | 19 | 3 | 22 |
| 2017 8 | 13 | 1 | 14 |
| 2017 7 | 7 | 5 | 12 |
| 2017 6 | 13 | 4 | 17 |
| 2017 5 | 8 | 4 | 12 |
| 2017 4 | 9 | 4 | 13 |
| 2017 3 | 7 | 3 | 10 |
| 2017 2 | 14 | 9 | 23 |
| 2016 1 | 15 | 3 | 18 |
| 2016 12 | 1 | 0 | 1 |
| 2015 11 | 1 | 0 | 1 |
| 2015 6 | 0 | 1 | 1 |
| 2015 4 | 1 | 1 | 2 |
Mostrar todo